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Jacqueline T. Hecht*†
From the Department of Pediatrics,* University of Texas Medical
School at Houston, Houston; and the Shriners Hospital for
Children,† Houston, Texas
Mutations in the cartilage oligomeric matrix protein
gene (COMP) cause pseudoachondroplasia (PSACH).
This dysplasia results from the intracellular retention
of mutant COMP protein and premature death of
growth-plate chondrocytes. Toward better under-
standing of these underlying mechanisms, we exam-
ined D469del-COMP activation of the unfolded pro-
tein response and cell death pathways in rat
chondrosarcoma cells. Using an inducible expression
system, we examined the effects of D469del-COMP
retention after 4 days of mRNA expression and then 5
days without inducing agent. Retention of D469del-
COMP stimulated Chop (Ddit3) and Gadd34
(Ppp1r15a) and triggered reactivation of protein
translation that exacerbated intracellular retention.
High levels of Nox4 and endoplasmic reticulum re-
ceptor stress-inducible Ero1 generated reactive oxy-
gen species, causing oxidative stress. Increased ex-
pression of Gadd genes and presence of H2AX
indicated that DNA damage was occurring. The pres-
ence of cleaved apoptosis inducing factor (tAIF) and
the absence of activated caspases indicated that reten-
tion of D469del-COMP triggers cell death in chon-
drocytes by necroptosis, a caspase-independent
programmed necrosis. Loss of growth-plate chondro-
cytes by necroptosis was also found in our pseudoa-
chondroplasia mouse model. These results suggest a
model in which D469del-COMP expression induces
persistent endoplasmic reticulum stress, oxidative
stress, and DNA damage, thus priming chondrocytes
for necroptosis. We define for the first time the pre-
cise mechanisms underlying D469del-COMP pathol-
ogy in pseudoachondroplasia and suggest that oxida-
tive stress and AIF may be promising therapeutic
targets. (Am J Pathol 2012, 180:738–748; DOI:
10.1016/j.ajpath.2011.10.033)
738Cartilage oligomeric matrix protein (COMP) is a pentam-
eric glycoprotein found in extracellular matrix (ECM) sur-
rounding chondrocytes and other cell types.1–7 COMP
(previously PSACH; also known as TSP5) belongs to the
thrombospondin family, which are a group of proteins
that mediate cell-cell and cell-matrix interactions.8 Multi-
ple roles and functions have been suggested for COMP,
including regulation of collagen fibril assembly, prolifer-
ation of chondrocytes, and interactions with other matrix
proteins such as collagens type II and IX and matrilin-3
(MATN3).8–17 Two autosomal dominant skeletal dyspla-
sias, pseudoachondroplasia and multiple epiphyseal
dysplasia/epiphyseal dysplasia, multiple 1 (MED/EDM1),
are caused by mutations in COMP.18,19 Pseudoachon-
droplasia is a short-limb type of dwarfism; MED/EDM1 is
a similar but milder condition, in which stature is not
dramatically reduced.20 Both conditions are associated
with abnormal joint architecture, joint erosion, and early
osteoarthritis.21 Pseudoachondroplasia and MED/EDM1
are defined at the cellular level by large endoplasmic retic-
ulum (ER) cisternae filled with lamellar-appearing mate-
rial.22 COMP localizes to these large ER cisternae, as do
collagens type II and IX andMATN3, and prematurely forms
an intracellular matrix network.3,23–27 This intracellular ma-
trix ultimately leads to premature chondrocyte death and
loss of growth-plate chondrocytes.24,28
Accumulation of misfolded proteins in the ER triggers
the unfolded protein response (UPR), a mechanism that
allows cells to cope with unfolded or misfolded pro-
teins.29–31 The UPR is composed of both adaptive and
apoptotic responses. The adaptive pathway functions to
repress general translation, enhance protein folding and,
degrade misfolded proteins. This is accomplished
through a complex network of interacting proteins and
transcription factors. For example, repression of general
translation occurs by inactivation of eukaryotic initiation
factor 2A (eIF2) through PKR-like endoplasmic reticu-
lum kinase (PERK; also known as eukaryotic translation
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folding requires the assistance of chaperone proteins.
However, persistent misfolded protein should be tar-
geted for degradation. When folding and degradation
mechanisms fail, the apoptotic arm of the UPR persists
through PERK and through DNA damage-inducible tran-
script 3 protein (DDIT3; hereafter referred to by the syn-
onym CHOP), which ultimately leads to cell death.34 Per-
sistent CHOP activation causes oxidative stress, which is
also a contributor to cell death.35
Cell death occurs either as programmed cell death or
as passive cell death.36–38 In programmed cell death,
there are two pathways, apoptosis and necroptosis. In
apoptosis, death occurs through the caspase-dependent
pathway, in which chromatin is condensed and DNA is
fragmented.38,39 In necroptosis, death occurs through
apoptosis inducing factor (AIF), a mitochondrial oxi-
doreductase that is translocated to the nucleus, trigger-
ing chromatin condensation and large-scale DNA frag-
mentation.37,40,41 Passive cell death or necrosis is
characterized by a loss of intracellular contents after
swelling of the cell and rupture of the plasma membrane,
often resulting from traumatic cellular events.36
Previously, in vivo and in vitro studies showed that ex-
pression of mutant COMP (T585M and D472Y) activated
the apoptotic arm of the UPR, including PERK and phos-
phorylation of eIF2.42,43 The presence of D472Y-COMP
increased levels of P-eIF2 and apoptosis, compared
with COS-7 cells expressing wild-type COMP (WT-
COMP).43 In mice expressing T585M-COMP MED/EDM1
mutation, the UPR was activated, although mutant COMP
retention was not detected in the ER of growth-plate
chondrocytes.42 Despite the lack of COMP retention, ex-
pression of T585M-COMP up-regulated transcription of
glucose-regulated protein 78 (Grp78; also known as
Hspa5, Bip), calreticulin (Crt; also known as Calr, Crtc),
and Chop, all of which are UPR genes. Additionally,
T585M expression caused increased cleavage of
caspase and reduction of B-cell lymphoma 2 (BCL-2)
levels in chondrocytes.42 These findings suggest that the
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ever, expression of T585M-COMP does not model the
pseudoachondroplasia chondrocyte pathology of intra-
cellular retention and thus may not represent the true
pseudoachondroplasia pathological mechanisms.
The present study was undertaken to define the UPR
mechanisms involved when D469del-COMP, the com-
mon mutation causing pseudoachondroplasia, is ex-
pressed and retained in chondrocytes. Human D469del-
COMP was expressed in rat chondrosarcoma (RCS) cells
from an inducible adenoviral delivery system that we
previously showed generates the pseudoachondroplasia
chondrocyte pathology. This system allowed examination
of the effect of retained D469del-COMP on the UPR. We
show that D469del-COMP triggers the UPR but does not
effectively activate the folding and degradation path-
ways. Furthermore, D469del-COMP expression induced
persistent ER and oxidative stress, affecting mitochon-
drial metabolism and thereby priming chondrocytes for
cell death through necroptosis.
Materials and Methods
Inducible Recombinant COMP Adenovirus
Construct
An inducible recombinant COMP adenovirus construct
(Figure 1A) was generated as described previously.44
This inducible system expresses either WT-COMP or
D469del-COMP using the reverse transactivator (rtTA).
D469del-COMP contains D469del, the common mutation
responsible for 30% of pseudoachondroplasia cases.45
Both human WT-COMP and D469del-COMP have a
FLAG-tag, and expression is driven by binding of doxy-
cycline (DOX)-activated rtTA to the tetracycline respon-
sive element (TRE) in the presence of DOX. Recombinant
adenovirus was produced, isolated, and quantified using
a Qbiogene AdEasy vector system kit (MP Biomedicals,
Solon, OH). Amplification was performed by Vector Bio-
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Figure 1. Expression of DOX-inducible COMP
in vitro. A: Schematic of the construct used to
express WT-COMP and D469del-COMP. The
ubiquitous cytomegalovirus promoter (pCMV)
drives expression of rtTA, which in turn drives
expression of the COMP gene in the presence of
DOX. B: Western blots show WT-COMP and
D469del-COMP expression. RCS cells were cul-
tured in the presence of 1 g/mL DOX for 2, 4,
and 7 days. -Actin was used as the loading
control. C and D: Coimmunostaining of infected
RCS cells with FLAG (green) and Golgi-specific
58K (red) at 4 days (C) or ER-specific CRT anti-
bodies (red) at 7 days (D). DAPI (blue) indicates
the nucleus. Scale bar  5 m.rtT
69delLabs (Philadelphia, PA).
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RCS cells were grown in monolayer with Dulbecco’s
modified Eagle’s medium supplemented with 10% FBS.
The cells were seeded in a 12-well plate at a density of
3  105 cells/well or in a 24-well plate at a density of
1.5  105 cells/well and infected with WT-COMP or
D469del-COMP adenovirus in Dulbecco’s modified Ea-
gle’s medium containing 2% of TET-free serum in the
presence or absence of 1 g/mL DOX. Multiplicity of
infection values for recombinant adenovirus were se-
lected to equalize for COMP expression levels in the
infected cells: MOI  40 for WT-COMP and MOI  120
for D469del-COMP. Ad-TeTOn (rtTA) was used as ade-
novirus infection control (Vector BioLabs). For all adeno-
virus infections, the cells were cultured in 2% tetracy-
cline-free FBS and Dulbecco’s modified Eagle’s medium
in the presence or absence of 1 g/mL DOX.
Histology and Immunohistochemistry
RCS cells were fixed in methanol at20°C for 10 minutes
either 4 or 7 days after infection. After three washes in
PBS-Tween 20, cells were blocked in 10% normal donkey
serum in PBS-Tween 20 for 1 hour at room temperature.
The cells were incubated with the following primary anti-
bodies: FLAG (green), 58K (red; Sigma-Aldrich, St. Louis,
MO), calreticulin (red; CRT; Santa Cruz Biotechnology,
Santa Cruz, CA) at 1:500 for 1 hour at 37°C. Secondary
antibodies Alexa Fluor 488 (FLAG rabbit) and Alexa Fluor
594 (58K goat and CRT goat) were incubated at 1:800
dilutions for 1 hour at 37°C (Life Technologies; Invitrogen,
Carlsbad, CA). Coverslips were mounted using ProLong
Gold with DAPI (blue; Life Technologies). Images were
captured on a BX51 inverted microscope (Olympus
America, Center Valley, PA) attached to a Retiga 2000RV
camera (QImaging, Surrey, BC, Canada) using Sim-
plePCI6 software (Hamamatsu Photonics, Hamamatsu,
Japan).
Immunoblot Analysis
Protein lysates were collected using radioimmunoprecipi-
tation assay buffer. These lysates contained both cellular
proteins and extracellular proteins found in the ECM sur-
rounding RCS cells. Lysates were sonicated on ice three
times for 15 seconds with a 45-second interval. Protein
concentrations were determined using a Pierce BCA pro-
tein assay (Thermo Fisher Scientific, Rockford, IL) and
samples were electrophoresed on gradient SDS-PAGE
gels (4% to 12%) and transferred to polyvinylidene diflu-
oride membranes. Western blots were incubated with
antibodies against FLAG (dilution 1:5000; Sigma-Al-
drich), eIF2, phospho-eIF2, caspase-3, phospho-His-
tone H2AX (Ser139), AIF (at 1:1000 dilutions; Cell Sig-
naling Technology, Inc), CHOP (GADD153), GADD34,
GRP78, and GRP94 (at 1:500 dilutions; Santa Cruz Bio-
technology). Secondary goat anti-rabbit IgG HRP was
incubated at 1:7000 dilution (Life Technologies). -actin-
HRP antibody (Abcam, Cambridge, MA) was used at
1:200,000 dilution to detect the loading control, -actin.Membranes were visualized using enhanced chemilumi-
nescence (GE Healthcare, Piscataway, NJ).
mRNA Quantification
Total RNA was isolated from the RCS cells using TRIzol
reagent (Life Technologies Corp) and treated with
RNase-free DNase1 (Ambion; Applied Biosystems, Aus-
tin, TX). cDNA was made using an iScript kit (Bio-Rad
Laboratories, Hercules, CA). Levels of UPR and Gapdh
mRNAs were measured by quantitative PCR using a
SYBR Green kit (Applied Biosystems). The primers used
are listed in Table 1. Relative changes in mRNA levels
were assessed using the comparative CT method. All of
the measurements were normalized to the endogenous
Gapdh mRNA.
Reactive Oxygen Species Assay
Reactive oxygen species (ROS) levels were measured
using an OxiSelect intracellular ROS assay kit (Cell Bio-
labs, San Diego, CA). Briefly, infected RCS cells were
incubated with the cell-permeable fluorogenic probe
2=,7=-dichlorofluorescein-diacetate (DCFH-DA). After
conversion of DCFH-DA into fluorescent DCF by ROS, the
fluorescence was read with a plate reader. The concen-
tration of DCF is proportional to the fluorescence inten-
sity, which is used to measure the ROS levels.
Gene Expression PCR Array
Expression of genes involved in oxidative stress and an-
tioxidant defense was analyzed using an RT2 Profiler PCR
array, PARN-065E, from Qiagen SABiosciences (Freder-
ick, MD). Three samples from the control (rtTA) and test
Table 1. Primers Used in Real-Time RT-PCR
Gene* Primer sequences
hCOMP Fwd-5=-GCAATGACACCATCCCAGAG-3=
Rev-5=-CTTGTCATCGTCGTCCTTGTAGTC-3=
Chop Fwd-5=-CCAGCAGAGGTCACAAGCAC-3=
Rev-5=-CGCACTGACCACTCTGTTTC-3=
Grp78 Fwd-5=-CCACCAGGATGCAGACATTG-3=
Rev-5=-AGGGCCTCCACTTCCATAGA-3=
Xbp1(S)† Fwd-5=-GTCTGCTGAGTCCGCAGCAGGT-3=
Rev-5=-CAGACTCAGAATCTGAAGAGGC-3=
Edem1 Fwd-5=-GCAATGAAGGAGAAGGAGAC-3=
Rev-5=-CCATATGGCGTAGTAGAAGGC-3=
Gadd34 Fwd-5=-AATCAGGACCCTGAGATTCCT-3=
Rev-5=-CTGGTCCTGCCCAGACAG-3=
Ero1b Fwd-5=-GACACCAAGACCCTTCTGCT-3=
Rev-5=-CTTTAATGACTTGGCCCCC-3=
Gadd45a Fwd-5=-CCGAAAGGATGGACACGGTG-3=
Rev-5=-TTATCGGGGTCTACGTTGAGC-3=
Gapdh Fwd-5=-AGTTCAACGGCACAGTCAAG-3=
Rev-5=-TACTCAGCACCAGCATCACC-3=
*Alternative gene names and symbols include the following. For Chop:
DNA damage-inducible transcript 3 protein (Ddit3). For Gadd34: protein
phosphatase 1, regulatory subunit 15A (Ppp1r15a). For Grp78: heat shock
70kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5).
†Spliced isoform.(D469del-COMP) groups were prepared accordingly to
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of cDNA were analyzed using a 4  96 plate format PCR
array. Real-time PCR detection was performed on ABI
7900HT system using a two-step cycling program rec-
ommended by the manufacturer (Applied Biosystems).
Software available through the SABiosciences website
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.
php) was used for data analysis.
Mitochondrial Membrane Potential Assay
Mitochondrial membrane potential in RCS cells was eval-
uated using a JC-1 mitochondrial membrane potential
assay kit (Cayman Chemical, Ann Arbor, MI). Briefly,
infected RCS cells were incubated with JC-1 staining
solution according to manufacturer’s protocol and were
analyzed by fluorescent microscopy. Healthy mitochon-
dria with J-aggregates (red) were visualized at 560/595
nm and unhealthy mitochondria with JC-1 monomers
(green) were visualized at 485/535 nm.
Results
Inducible Expression of D469del-COMP in RCS
Cells Generates the Pseudoachondroplasia
Cellular Phenotype
To study the effect of human D469del-COMP in chondro-
cytes, we used a DOX-inducible adenoviral expression
system to generate the pseudoachondroplasia chondro-
cyte phenotype in RCS cells (Figure 1A). RCS cells were
used because they maintain the chondrocyte phenotype
and produce ECM proteins in monolayer culture,
whereas primary chondrocytes quickly dedifferentiate
and cease to synthesize matrix proteins.46 We have pre-
viously established that D469del-COMP-transfected RCS
cells mimic the pseudoachondroplasia chondrocyte traf-
ficking defect.47 RCS cells were infected with either WT-
COMP or D469del-COMP adenovirus, and COMP ex-
pression was induced by 1 g/mL of DOX for 2, 4, and 7
days. WT-COMP and D469del-COMP were first detectedat 4 days after infection and were present at 7 days
(Figure 1B). The protein lysates contained both intra- and
extracellular proteins. To evaluate the cellular trafficking
of each recombinant COMP protein, coimmunostaining
was performed with either 58K (Golgi-specific) or CRT
(ER-specific) antibodies and a FLAG antibody that spe-
cifically recognizes recombinant COMP. WT-COMP co-
localized with the 58K Golgi-specific marker (Figure 1C),
indicating that the WT-COMP is processed through the
ER to the Golgi and is being exported in the ECM. In
contrast, D469del-COMP colocalized with CRT, indi-
cating that the D469del-COMP is retained in the ER
(Figure 1D). These results demonstrate that inducible
D469del-COMP expression in RCS cells recapitulates
the chondrocyte trafficking pathology seen in pseudo-
achondroplasia and in our mouse model of pseudo-
achondroplasia.18,19,22,25,27,48
Continuous Expression of COMP Induces
Components of the UPR in RCS Cells
After confirming that this inducible system models the
pseudoachondroplasia chondrocyte phenotype, we then
examined which UPR pathways were triggered by WT-
COMP or D469del-COMP after induction of expression
for 2 and 4 days. The mRNA and protein levels of genes
involved in the UPR pathways were assessed. After 2
days of expression, the presence of D469del-COMP in-
duced higher levels of Grp78, X-box binding protein 1
spliced isoform [Xbp1(S)], Chop, and ER degradation-
enhancing -mannosidase-like 1 (Edem1) mRNAs, com-
pared with cells expressing WT-COMP (Figure 2, A–D);
however, protein levels of GRP78, GRP94, and protein
disulfide isomerase (PDI), all folding chaperones, were
similar in both WT-COMP and D469del-COMP express-
ing cells (Figure 2E). After 4 days of expression, D469del-
COMP increased Chop and Edem1 mRNA (Figure 2, C
and D). The presence of P-eIF2 by Western blot indi-
cates that the UPR proapoptotic pathway is induced after
2 days of COMP expression (Figure 2F). CHOP protein
was not detectable until after 4 days of expression (Fig-
gure 2. D469del-COMP expression in RCS cells triggers UPR. A–D: mRNA
vels of UPR genes Grp78 (A), Xbp1(S) (B), Edem1 (C), and Chop (D) were
alyzed by qRT-PCR after expression of WT-COMP (white bars) and D469del-
MP (black bars) for 2 and 4 days. All qRT-PCR measurements were nor-
alized to GAPDH. Assays were performed in triplicate; error bars indicate 
. **P  0.01. E and F: Levels of UPR proteins from RCS cells expressing
T-COMP or D469del-COMP for 2 and 4 days were analyzed by Western blot:
rp78, Grp94, and PDI (E); CHOP, P-eIF2, abd eIF2  (F). -Actin was used
the loading control.Fi
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(Figure 2D). These results show that folding (Grp78) and
degradative [Edem1 and Xbp1(S)] pathways are induced
at the mRNA level only. In contrast, induction of mRNA
and protein levels of CHOP shows that the apoptotic arm
is activated.
Retained D469del-COMP Sustains the
Apoptotic UPR Pathway in RCS Cells
After determining that 4 days of D469del-COMP expres-
sion was necessary for substantial intracellular retention
and CHOP protein expression, we assessed the effect of
retained D469del-COMP on the UPR pathway genes.
WT-COMP or D469del-COMP expression was induced
with DOX for 4 days (the expression period), and then
DOX was removed and RCS cells were cultured for 5
days more (the retention period). To control for any ef-
fects of adenoviral infection, the TetOn adenovirus that
expresses only reverse Tet transactivator (rtTA) was
used. The absence of DOX turns off recombinant COMP
synthesis, and during this period the effect of retained
D469del-COMP was assessed. The levels of both WT-
COMP and D469del-COMP mRNA dramatically de-
creased after removal of DOX (Figure 3A), indicating that
removal of DOX effectively shuts down synthesis of
COMP. High levels of intracellular D469del-COMP de-
tected by Western blot after 5 days without DOX show
that D469del-COMP was retained (Figure 3B). During the
retention period, the levels of Grp78, Xbp1(S), Edem1,
and ChopmRNA were significantly increased in cells with
D469del-COMP, compared with controls (Figure 3, C–F).
Moreover, levels of Xbp1(S) and Chop mRNAs in-
creased approximately twofold from the expression to
the retention period, even though there was no mRNA
expression of D469del-COMP during the 5-day reten-
tion period (Figure 3, D and F). The levels of Grp78 and
Edem1 remained unchanged during both expression
and retention periods (Figure 3, C and E), indicating
that retention of D469del-COMP does not effectively
trigger the folding and degradation pathways of the
UPR in RCS cells.Intracellular D469del-COMP Retention
Increases Oxidative Stress
After determining that CHOP is critical to the D469del-
COMP pseudoachondroplasia cellular pathology, we
evaluated oxidative stress, which is known to be a con-
sequence of sustained CHOP activation.35 Endoplasmic
reticulum oxidoreductase 1beta (ERO1) is an enzyme
induced by ER stress and involved in the generation of
ROS.49 Ero1 was significantly increased in the cells
expressing D469del-COMP and continued to increase
during the retention period (Figure 4A).
To determine whether D469del-COMP retention alters
the redox state of chondrocytes, we measured the level
of intracellular ROS using DCF, which measures the con-
version of the DCFH-DA probe by ROS.50,51 The level of
re 3. Intracellular D469del-COMP maintains apoptotic UPR pathway in RCS
. A and B: Levels of hCOMP mRNA and protein during the expression (dark
) and retention periods (light bars) were assessed using qRT-PCR (A) and
tern blot (B), in which human COMP expression was compared between
tive controls, one with no virus (NV) and the other with rtTA virus (TA), and
COMP and D469del (MT)-COMP expressing viruses. -Actin was used as the
ing control for Western blots. C–F: mRNA levels of Grp78 (C), Xbp1(S) (D),
1 (E), and Chop (F) were analyzed by qRT-PCR during the WT-COMP and
9del-COMP expression and retention periods, normalized to GAPDH. Assays
performed in triplicate; error bars indicate  SD. *P  0.05; **P  0.01.
Figure 4. Intracellular D469del-COMP induces generation of ROS in RCS
cells. A: mRNA levels of Ero1 were analyzed by qRT-PCR after the WT-
COMP and D469del-COMP expression (dark bars) and retention (light bars)
periods. Measurements were normalized to GAPDH. Assays were performed
in triplicate; error bars indicate  SD. *P  0.05; **P  0.01. B: Intracellular
levels of ROS were measured in RCS cells after the WT-COMP and D469del-
COMP expression and retention periods using a fluorogenic probe, DCFH-Figu
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fected with D469del-COMP, compared with WT-COMP or
rtTA, during both the expression and the retention peri-
ods (Figure 4B). After determining that ROS stress plays
a role in the D469del-COMP pseudoachondroplasia
chondrocyte pathology, we evaluated the expression of
84 genes involved in oxidative stress and antioxidant
defense using a PCR array (RT2 Profiler PARN-065E;
Qiagen). The genes showing a twofold or greater differ-
ential expression of antioxidant and oxidative stress
genes during the retention period are listed in Table 2.
Intracellular D469del-COMP up-regulated the expres-
sion of many antioxidant genes 2- to 16-fold. In contrast,
thioredoxin interacting protein (TXNIP) was induced 30-
fold by D469del-COMP retention. TXNIP is known to in-
hibit a major antioxidant, thioredoxin (TRX).52 Most im-
portantly, retention of D469del-COMP increased NADPH
oxidase 4 (NOX4) 100-fold. NOX4 is an enzyme in-
volved in ROS generation during the UPR. In addition,
dual oxidase 2 (Duox2), an oxidative stress response
gene, was down-regulated approximately threefold. Two
solute carrier family 38 genes, Slc38a1 and Slc38a4, both
involved in transport of neutral amino acids, were up-
regulated 19- and 98-fold, respectively, in the retention
Table 2. Genes Involved in Oxidative Stress That Are Regulated
Rat gene symbol
Antioxidants
Apc Adenomatous
Gsr Glutathione re
Gstk1 Glutathione-S-
Prdx3 Peroxiredoxin
Prdx5 Peroxiredoxin
Prdx6 Peroxiredoxin
Ptgs1 Prostaglandin
Ptgs2 Prostaglandin
Tmod1 Tropomodulin
Txnrd1 Thioredoxin re
Txnrd2 Thioredoxin re
Genes involved in reactive oxygen species
metabolism
Genes involved in superoxide metabolism
Nox4 NADPH oxida
Oxidative stress responsive genes
Als2 Amyotrophic l
Apoe Apolipoprotein
Duox2 Dual oxidase
Ercc2 Excision repai
deficiency,
Nqo1 NAD(P)H deh
Park7 Parkinson dise
Prnp Prion protein
Psmb5 Proteasome (p
Txnip Thioredoxin-in
Oxygen transporter genes
Cygb Cytoglobin
Dnm2 Dynamin 2
Fancc Fanconi anem
Hba-a2 Hemoglobin a
Ift172 Intraflagellar t
Slc38a1 Solute carrier
Slc38a4 Solute carrier
Out of 84 genes present in the rat oxidative stress and antioxidant d
Frederick, MD), only genes that presented a twofold or greater change wperiod. Neutral amino acids play a role in the biosynthe-sis of reduced glutathione (GSH), a major intracellular
antioxidant.53 Taken together, these results indicate that
D469del-COMP retention generates oxidative stress in
RCS cells by substantially increasing the expression of
enzymes involved in ROS production (Ero1 and Nox4)
and by limiting antioxidant activity through Txnip.
Intracellular D469del-COMP Induces DNA
Damage
To determine whether the oxidative stress generated by
D469del-COMP retention causes DNA damage, we as-
sessed the mRNA levels of DNA damage marker genes,
including growth arrest and DNA damage 34 (Gadd34),
Gadd45A, and assessed the protein level of Ser139-
phosphorylated histone H2AX (H2AX). Expression of
Gadd34 was significantly increased during the D469del-
COMP expression period (Figure 5A). Gadd34 is directly
activated by CHOP.35 Gadd45A gene expression was
higher in cells expressing and retaining D469del-COMP
(Figure 5B). Similarly, levels of H2AX were increased
during D469del-COMP the expression and retention pe-
riods (54% and 43%, respectively), compared with WT-
ention of MT-COMP in RCS Cells Compared with Control rtTA
Gene name Fold change P value
sis coli 11.32 0.0018
e 2.35 0.0065
rase kappa1 4.42 0.032
6.15 0.0057
3.48 0.001
3.53 0.009
eroxide synthase 1 2.08 0.01
eroxide synthase 2 16.56 0.037
12.29 0.0031
e 1 5.36 0.0001
e 2 8.36 0.001
107.55 0.0030
clerosis (juvenile) homolog human 4.53 0.0005
3.73 0.0001
2.77 0.037
-complementing rodent repair
mentation group 2
5.09 0.0235
nase, quinone 1 4.25 0.0001
utosomal recessive, early onset) 7 2.34 0.0145
10.58 0.0006
e, macropain) subunit, beta type 5 2.26 0.0001
g protein 29.89 0.0016
4.85 0.0031
4.17 0.0402
plementation group C 3.92 0.0046
dult chain 2 8.85 0.0002
rt 172 homolog (Chlamydomonas) 3.73 0.0025
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causes DNA damage in RCS cells.
Intracellular D469del-COMP Induces Cell Death
through Necroptosis
To determine which type of cell death is elicited by re-
tained D469del-COMP, we evaluated cleavage of
caspases 3, 8, 9, and 12, mitochondrial integrity, and AIF
(necroptosis specific). Expression and retention of
D469del-COMP did not trigger activation of caspase 3
(Figure 6A). Similar results were obtained for caspases 8,
9, and 12 (data not shown). We also assessed the levels
of survivin, a member of the inhibitor of apoptosis (IAP)
family that inhibits caspase cleavage.54,55 During the re-
tention period, D469del-COMP expressing cells showed
a higher level of survivin than the controls, which may
explain the lack of caspase cleavage (Figure 6B).
Mitochondrial membrane potential is often compro-
mised during cell death and therefore, we investigated
whether mitochondria are involved in D469del-COMP-
induced cell death. Mitochondrial transmembrane poten-
tial (m) was measured by detecting color changes in
fluorescent dye JC-1 (5,5=,6,6=-tetrachloro-1, 1=,3,3=-tet-
Figure 5. Intracellular D469del-COMP induces DNA damage in RCS cells.
mRNA levels of Gadd34 (A) and Gadd45a (B) were analyzed by qRT-PCR
after the WT-COMP and D469del-COMP expression (dark bars) and retention
(light bars) periods. Measurements were normalized to GAPDH. Assays were
performed in triplicate; error bars indicate  SD. *P  0.05; **P  0.01. C:
Levels of H2AX in RCS cells after the WT-COMP and D469del-COMP ex-
pression and retention periods were analyzed by Western blot. H2AX
expression was compared between negative controls, one with no virus (NV)
and the other with rtTA virus (TA), and WT-COMP and D469del (MT)-COMP
expressing viruses. -Actin was used as the loading control.raethylbenzimidazolylcarbocyanine iodide). The JC-1 mono-A  
D
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Figure 6. Intracellular D469del-COMP induces necroptosis in RCS cells. Protein
levels of cleaved caspase 3 (A) and survivin (B) were analyzed byWestern blot after
the WT-COMP and D469del-COMP expression and retention periods. Expression
was comparedbetweennegative controls, onewith novirus (NV) and theotherwith
rtTA virus (TA), and WT-COMP and D469del (MT)-COMP expressing viruses. C:
Mitochondrial membrane potential was measured by detecting color changes in
fluorescence of the dye JC-1. RCS cells were cultured in the presence of 1 g/mL
DOX for expression (EXP) and retention (RET) periods. JC-1 changes color from
green to red as it forms J-aggregates in healthy mitochondria with elevated mem-
brane potential; it remains green in the monomeric form in mitochondria with low
membrane potential. The loss of red fluorescence and increased greenmitochondria
are indicators of low mitochondrial membrane potential and cell death. D: Protein
levels of AIF and cleaved AIF (asterisk) were analyzed by Western blot after
expression and retention periods. -Actin was used as the loading control.
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healthy mitochondria with high membrane potential.56 In
contrast, unhealthy mitochondria have a low membrane
potential and form few J-aggregates. D469del-COMP re-
tention compromises mitochondrial membrane potential,
because no J-aggregates were detected during the re-
tention period (green) (Figure 6C). In contrast, the control
cells had a mixture of healthy and unhealthy mitochondria
(red and green; Figure 6C).
In a proapoptotic environment, AIF is cleaved, released
from themitochondria to the cytosol, and translocated to the
nucleus, where it induces caspase-independent cell death
(ie, programmed necrosis, or necroptosis). We next exam-
ined whether AIF is involved in the cell death of chondro-
cytes during the D469del-COMP retention period. More
cleaved AIF was detected (12%) in cells retaining
D469del-COMP, compared with controls (2.6%; Figure
6D). Moreover, the amount of full-length AIF with expres-
sion of WT-COMP and D469del-COMP was equivalent
when normalized to -actin. These results demonstrate
that D469del-COMP retention in chondrocytes negatively
affects mitochondria function and triggers cell death
through necroptosis.
Discussion
Pseudoachondroplasia is a well-characterized, severe,
and debilitating dwarfism caused by mutations in
COMP.18,19 It has long been known that the pseudoa-
chondroplasia chondrocyte ER becomes massively en-
gorged, but the pathological mechanism or mechanisms
have been difficult to unravel.22 Recent in vivo and in vitro
studies have shown that different COMP mutations acti-
vate the UPR and that this activation is not dependent on
whether mutant COMP is retained.42,43 However, none
of these studies followed the UPR beyond activation, and
thus there is little information about the actual processes
that lead to chondrocyte death and short-limb dwarfism.
To better understand the process by which mutant COMP
expression and retention mediates chondrocyte toxicity,
we expressed the common D469del-COMP mutation in a
RCS pseudoachondroplasia model system. Although
both the adaptive (protein folding and degradation) and
apoptotic arms of the UPR are activated, only the apop-
totic arm is functional (Figure 7). Moreover, we show that
necroptosis, a specific type of apoptosis, causes cell
death through downstream CHOP signaling and oxida-
tive stress. These novel results now define the mecha-
nisms underlying this ER chondrocyte storage disorder.
Importantly, this mechanism has been confirmed in our
transgenic D469del-COMP (D469del) mouse that exhib-
its the phenotypic and chondrocyte pathology of pseudo-
achondroplasia.48
Necroptosis is a type of cell death that has features of
both apoptosis (programmed cell death) and necrosis
(passive cell death).57 Mitochondrial dysfunction and ox-
idative stress play important roles in necroptosis.40,57
Mild oxidative stress causes apoptosis through the acti-
vation of caspase cleavage.58 In contrast, excessive or
prolonged oxidative stress suppresses cleavage ofcaspases and mediates cell death through caspase-in-
dependent mechanisms.59 Here, we show that D469del-
COMP retention lowers mitochondrial transmembrane
potential and induces oxidative stress through Ero1 and
Nox4 (Figures 4 and 6C). Additionally, no caspase 3
activation or cleavage was detected (Figure 6A), and
similarly none for caspases 8, 9, and 12 (data not shown),
indicating that the caspase-dependent apoptosis is not
activated by D469del-COMP. Other studies have shown
that high levels of ROS inhibit activation of caspases, and
this is likely occurring in RCS cells that express and retain
D469del-COMP.58,59 Additionally, two necroptosis exe-
cutioners have been identified: mitochondrial protein AIF
and receptor interacting protein (RIP-1).40,41,60 Necrop-
tosis is initiated by the association of cleaved AIF with
H2AX, a marker of DNA double-strand breaks. Subse-
quently, the endonuclease CypA is recruited to join the
H2AX/AIF complex and initiates chromatin condensa-
tion, DNA fragmentation, and finally cell death. We show
that cleaved AIF and H2AX are both up-regulated by
retained D469del-COMP (Figure 6D). Taken together,
these findings indicate that the mechanisms underlying
necroptosis, rather than apoptosis, are occurring in the
RCS cells expressing and retaining D469del-COMP.
The generation of ROS and ER stress are closely
linked.49 ROS production during UPR stress involves sev-
eral enzymes, including ERO1, PDI, and NOX4.49
ERO1maintains an oxidative environment necessary for
correct protein folding in the ER.61 D469del-COMP reten-
UPR 
GADD34 ERO1β 
DNA damage 
  General 
Translation 
NOX4 
Mitochondria 
Endoplasmic Reticulum 
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ROS 
ΔΨm 
Nucleus 
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P-eIF2α 
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Figure 7. Model of UPR and apoptosis induction by intracellular D469del-
COMP retention. Intracellular D469del-COMP retention triggers the UPR.
Several adaptive mechanisms of the UPR pathway (decreased translation,
refolding, and ER-associated degradation) are unable to successfully restore
normal ER function. Activation of the proapoptotic CHOP UPR pathway
results in expression of GADD34, which in turn restarts protein translation,
thereby exacerbating D469del-COMP accumulation. Overexpression of
CHOP-dependent ERO1 and NOX4 leads to increased ROS production and
subsequently to oxidative stress. Oxidative stress causes DNA damage (ele-
vated levels of Gadd45A mRNA and protein H2AX) and decreased mito-
chondrial membrane potential (m). Ultimately, tAIF is released from the
impaired mitochondria and translocates to the nucleus, where it associates
with H2AX to initiate necroptosis.tion increased expression of CHOP and Ero1 (CHOP-
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descriptions of the CHOP-induced UPR pathway.35 Nox4
expression was also markedly increased in response to
retained D469del-COMP (Table 2). Increases in Ero1
and Nox4 are known to generate ROS, which could fur-
ther stimulate incorrect disulfide bonding, leading to ad-
ditional protein misfolding and impairment of chaperone
function.61 In addition, Txnip, an important inhibitor of the
antioxidant thioredoxin was strongly induced after
D469del-COMP retention, most likely exacerbating oxi-
dative stress. Furthermore, our results showed that DNA
damage occurred in cells retaining D469del-COMP, as
indicated by up-regulation of Gadd45A expression and
the presence of H2AX. Extensive DNA damage is a
well-recognized mediator of cell death, and D469del-
COMP-induced DNA damage is most likely due to oxida-
tive stress. Overall, our data suggest a model in which
persistent presence of misfolded proteins in the ER re-
sults in excessive oxidation, causing damage to DNA and
ultimately cell death through necroptosis (Figure 7).
Retention of D469del-COMP indicates that UPR
clearance mechanisms are ineffective, and here we
show that, even though the adaptive UPR responses
are activated, downstream processes do not proceed.
D469del-COMP induced more protein-folding capacity
and ER-associated degradation, through increased syn-
thesis of Xbp1(S), Grp78, and Edem1 (Figures 2 and 3).
However, despite increased mRNA levels, D469del-
COMP retention did not stimulate an increase in the
Grp78 protein needed for protein folding (Figure 2).
Edem1 is an ER enzyme involved in retrotranslocation of
misfolded proteins to the cytoplasm and targeting the
proteins for proteasomal degradation. D469del-COMP
was not cleared from the ER, even though the level of
Edem1 mRNA was increased after D469del-COMP ex-
pression in RCS cells, indicating that the UPR clearance
mechanisms are ineffective.
A calcium scaffold is necessary for correct COMP
folding in the ER.62 The D469del mutation causes the
loss of calcium-binding, which negatively affects the
ability of COMP to undergo protein folding,11,63,64 and so
D469del-COMP is likely resistant to refolding efforts. Re-
petitive folding attempts by chaperones would therefore
be unsuccessful, which is likely another cause of exces-
sive ROS production.35,65 Additionally, we have previ-
ously shown that retained D469del-COMP prematurely
associates with other ECM proteins in the ER and assem-
bles a matrix network in chondrocytes both in vivo and in
vitro.26,27 The matrix assembly likely traps D469del-
COMP, limiting retrotranslocation from the ER to the pro-
teasome.26,27 Taken together, these and previous results
suggest that D469del-COMP cannot be delivered to the
proteasome, because the size of the retained material
renders Edem1 ineffective.
Thus far, we have shown that UPR mechanisms to
clear retained D469del-COMP from RCS cells are inef-
fective, thus driving UPR toward the CHOP-dependent
proapoptotic pathway. Several other studies have evalu-
ated the UPR in cells expressing different COMP muta-
tions. Expression of mutant D472Y COMP in COS-7 cells
increased i) the level of P-eIF2, ii) the number of TUNEL-positive cells, and iii) DNA fragmentation.43 In the mutant
T585M COMP knock-in mouse, increases in P-eIF2 pro-
tein and Chop mRNA levels generated mild rER stress,
despite little accumulation.42 Increases in caspase 12
cleavage and TUNEL-positive cells with a decrease in
BCl-2 expression were observed.42 In both studies, how-
ever, D469del-COMP was not retained, which may limit
the level of ER stress and thereby limit ROS production. In
those models, mild oxidative stress may lead to apoptotic
cell death.58,59 In our RCS model, which has extensive
D469del-COMP retention similar to that of pseudoachon-
droplasia, high levels of ROS cause cell death through
necroptosis. Moreover, we show in our D469del-COMP
mouse, which recapitulates the pseudoachondroplasia
chondrocyte phenotype, that oxidative stress and
cleaved AIF are up-regulated, indicating that necroptosis
is occurring in growth-plate chondrocytes.40,41
The role of oxidative stress in D469del-COMP chon-
drocyte pathology has not previously been appreciated.
The present novel findings suggest that antioxidants and
drugs that reduce ROS production may be beneficial for
pseudoachondroplasia and MED/EDM1. These easily ac-
cessible therapies, which have a long history of safe and
effective use, provide a new avenue to address the un-
derlying chondrocyte pathology. This class of therapeu-
tics has been shown to improve protein secretion and
cellular function with other ER-stress-related disorders.66
Specifically, a mixture of dietary antioxidants and anti-
inflammatories improved cognitive function in an Alzhei-
mer disease mouse model.67 Additionally, a combination
of vitamin C and E has been shown to decrease inflam-
mation and oxidative stress and to improve insulin sen-
sitivity in type 2 diabetes.68–70 Investigations of exciting
new oxidative stress therapies suggest that limiting ROS
production by use of NOX inhibitors may be more effec-
tive than antioxidant therapy.71 At present, only symp-
tomatic interventions are available for pseudoachondro-
plasia and MED/EDM1. Oxidative stress therapy is a
novel approach to prevent premature chondrocyte loss
and dwarfism.
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